PGEN stock forecast
Our latest prediction for Precigen Inc's stock price was made on the Oct. 13, 2021 when the stock price was at 4.60$.
In the short term (2weeks), PGEN's stock price should underperform the market by -3.14%. During that period the price should oscillate between -11.93% and +10.30%.
In the medium term (3months), PGEN's stock price should underperform the market by -7.30%. During that period the price should oscillate between -40.05% and +28.09%.Get email alerts
Create a solid portfolio with PGEN
About Precigen Inc
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The Company's technologies enable to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
At the moment the company generates 101M USD in revenues.
On its last earning announcement, the company reported a loss of -0.60$ per share.
The book value per share is 0.42$
Three months stock forecastOct. 13, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|